{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:05:08Z","timestamp":1789538708517,"version":"build-2803163510"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010733","name":"B\u00f8rnecancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007403","name":"Dagmar Marshalls Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Allogeneic hematopoietic stem cell transplantation (HSCT) in children remains challenged by chronic graft-versus-host-disease (cGvHD), significantly affecting morbidity and survival. While aberrant peripheral B-cell reconstitution has been implicated in cGvHD, B-cell development in the bone marrow (BM) remains less explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We investigated the B-cell reconstitution in BM samples and its potential to predict cGvHD in 76 children undergoing HSCT for acute leukemia (2010-2021) by blinded immunophenotypic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Children developing cGvHD exhibited delayed B-cell reconstitution in the BM with significantly lower proportions of total B cells and early B-cell precursors (BCP) I and II from +2 months to +9 months post-HSCT (all p&amp;lt;0.008) and reduced BCPIII and mature B cells at later time points compared to those without cGvHD (all p&amp;lt;0.05). In multivariable Cox proportional hazards models, low proportions of total B cells, BCPI, and BCPII at month +2 and month +3 were independent risk factors for cGvHD (HR=6.9-14.1, all p&amp;lt;0.017). At +2 months after HSCT, ROC analysis for predicting cGvHD with cut-off values of 0.16% (BCPI) and 0.99% (BCPII), yielded a sensitivity of 1.0 and a specificity of 0.69, while a cut-off value of 2.25% for total B cells resulted in a sensitivity of 0.90 and a specificity of 0.69.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings support previous evidence of disturbed B-cell reconstitution in cGvHD and suggest that phenotypic monitoring of BM B cells following pediatric HSCT may facilitate early cGvHD risk stratification. As BM assessments are routinely performed after HSCT, such monitoring could be readily integrated into existing clinical workflows.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1923247","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:34:42Z","timestamp":1789536882000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Delayed B-cell reconstitution in the bone marrow precedes the development of chronic graft-versus-host disease following pediatric hematopoietic stem cell transplantation"],"prefix":"10.3389","volume":"17","author":[{"given":"Elisa Christine","family":"Nimskov-Peen","sequence":"first","affiliation":[{"name":"Hematopoietic Stem Cell Transplantation and Primary Immune Deficiency, Department of Pediatric and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet","place":["Copenhagen, Denmark"]},{"name":"Department of Clinical Immunology, Copenhagen University Hospital Rigshospitalet","place":["Copenhagen, Denmark"]},{"name":"Institute for Inflammation Research, Department of Rheumatology and Spine Disease, Copenhagen University Hospital Rigshospitalet","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Hematopoietic Stem Cell Transplantation and Primary Immune Deficiency, Department of Pediatric and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet","place":["Copenhagen, Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine","family":"Kielsen","sequence":"additional","affiliation":[{"name":"Hematopoietic Stem Cell Transplantation and Primary Immune Deficiency, Department of Pediatric and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet","place":["Copenhagen, Denmark"]},{"name":"Institute for Inflammation Research, Department of Rheumatology and Spine Disease, Copenhagen University Hospital Rigshospitalet","place":["Copenhagen, Denmark"]},{"name":"Department of Immunology and Microbiology, University of Copenhagen","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne Vibeke","family":"Marquart","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Copenhagen University Hospital Rigshospitalet","place":["Copenhagen, Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.2453","article-title":"Assessment of late mortality risk after allogeneic blood or marrow transplantation performed in childhood","volume":"4","author":"Holmqvist","year":"2018","journal-title":"JAMA Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.05.009","article-title":"Allogeneic stem cell transplantation from HLA-mismatched donors for pediatric patients with acute lymphoblastic leukemia treated according to the 2003 BFM and 2007 International BFM studies: Impact of disease risk on outcomes","volume":"24","author":"Dalle","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-161638","article-title":"The role of B cells in the pathogenesis of graft-versus-host disease","volume":"114","author":"Shimabukuro-Vornhagen","year":"2009","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.9.3128","article-title":"Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: Long-term results of a randomized study","volume":"100","author":"Mohty","year":"2002","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-003954","article-title":"Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: A report from the Bone Marrow Transplant Survivor Study","volume":"108","author":"Fraser","year":"2006","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02053.x","article-title":"Quality of life in 244 recipients of allogeneic bone marrow transplantation","volume":"110","author":"Chiodi","year":"2000","journal-title":"Br J Haematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-082933","article-title":"Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor study","volume":"110","author":"Bhatia","year":"2007","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.05.004","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. The 2014 clinical trial design working group report","volume":"21","author":"Martin","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.602547","article-title":"Potential novel biomarkers in chronic graft-versus-host disease","volume":"11","author":"Crossland","year":"2020","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The biology of chronic graft-versus-host disease: A task force report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease","volume":"23","author":"Cooke","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.325","article-title":"Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein","volume":"25","author":"Yong","year":"2011","journal-title":"Leukemia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-567834","article-title":"Aberrant B-cell homeostasis in chronic GVHD","volume":"125","author":"Sarantopoulos","year":"2015","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.05.019","article-title":"Selectively T cell-depleted allografts from hla-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic Malignancies","volume":"17","author":"Mielke","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.788360","article-title":"Value of autoantibody expression during long-term follow-up in paediatric ALL patients after allogeneic haematopoietic stem cell transplantation","volume":"9","author":"Lawitschka","year":"2021","journal-title":"Front Pediatr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-668145","article-title":"Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice","volume":"127","author":"Jin","year":"2016","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-364414","article-title":"Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans","volume":"119","author":"Srinivasan","year":"2012","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.9589","article-title":"The impact of acute and chronic graft-versus-host disease on normal and Malignant B-lymphoid precursors after allogeneic stem cell transplantation for B -lineage acute lymphoblastic leukemia","volume":"91","author":"S\u00e1nchez-Garc\u00eda","year":"2006","journal-title":"Haematologica"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e328353bc7d","article-title":"Immune reconstitution after hematopoietic cell transplantation","volume":"19","author":"Bosch","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199606)52:2<82::AID-AJH3>3.0.CO;2-1","article-title":"Lack of B cell precursors in marrow transplant recipients with chronic graft-versus-host disease","volume":"52","author":"Storek","year":"1996","journal-title":"Am J Hematol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01879","article-title":"National institutes of health\u2013defined chronic graft-vs.-host disease in pediatric hematopoietic stem cell transplantation patients correlates with parameters of long-term immune reconstitution","volume":"10","author":"Lawitschka","year":"2019","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.10.009","article-title":"Elevated numbers of immature\/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease","volume":"14","author":"Greinix","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.11.010","article-title":"CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease","volume":"21","author":"Greinix","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.07.008","article-title":"Current definitions and clinical implications of biomarkers in graft-versus-host disease","volume":"28","author":"Bidgoli","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00782","article-title":"B cell reconstitution and influencing factors after hematopoietic stem cell transplantation in children","volume":"10","author":"Van Der Maas","year":"2019","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBMT.2017.05.005","article-title":"Humoral immune reconstitution kinetics after allogeneic hematopoietic stem cell transplantation in children: A maturation block of IgM memory B cells may lead to impaired antibody immune reconstitution","volume":"23","author":"Abdel-Azim","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013442","article-title":"Associations between acute and chronic graft-versus-host disease","volume":"8","author":"Tamaki","year":"2024","journal-title":"Blood Adv"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/95.6.816","article-title":"B-cell precursors in normal pediatric bone marrow","volume":"95","author":"Caldwell","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.2.489","article-title":"Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation","volume":"98","author":"Storek","year":"2001","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.03.005","article-title":"Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD development","volume":"18","author":"Fedoriw","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1182\/blood-2005-09-3623","article-title":"Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations","volume":"107","author":"Zhang","year":"2006","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.11.007","article-title":"Biology of Blood and Marrow Transplantation comprehensive B cell phenotyping profile for chronic graft-versus-host disease diagnosis","volume":"25","author":"Rozmus","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-177840","article-title":"Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease","volume":"113","author":"Sarantopoulos","year":"2009","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Sci (1979)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06347.x","article-title":"The establishment of early B cell tolerance in humans: Lessons from primary immunodeficiency diseases","volume":"1246","author":"Meffre","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2008.09.001","article-title":"B-cell tolerance checkpoints in health and autoimmunity","volume":"20","author":"Meffre","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003186","article-title":"Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE\/PBMTC 1202 studies","volume":"135","author":"Schultz","year":"2020","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5045\/kjh.2012.47.1.44","article-title":"Factors influencing lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation in children","volume":"47","author":"Bae","year":"2012","journal-title":"Korean J Hematol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4284","article-title":"Identification and characterization of circulating human transitional B cells","volume":"105","author":"Sims","year":"2005","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-295766","article-title":"Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia","volume":"117","author":"Kuzmina","year":"2011","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.01.021","article-title":"Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease","volume":"20","author":"Jacobson","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-243071","article-title":"Complement receptor 2\/CD21- human naive B cells contain mostly autoreactive unresponsive clones","volume":"115","author":"Isnardi","year":"2010","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.05.010","article-title":"Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches","volume":"20","author":"Thien","year":"2004","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051283","article-title":"BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway","volume":"202","author":"Craxton","year":"2005","journal-title":"J Exp Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-438911","article-title":"B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways","volume":"120","author":"Allen","year":"2012","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008040","article-title":"BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation","volume":"137","author":"Jia","year":"2021","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-533562","article-title":"Increased BCR responsiveness in B cells from patients with chronic GVHD","volume":"123","author":"Allen","year":"2014","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/nejmoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease \u2014 a case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-0233","article-title":"Rituximab for steroid-refractory chronic graft-versus-host disease","volume":"108","author":"Cutler","year":"2006","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1923247\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:34:44Z","timestamp":1789536884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1923247\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2026.1923247"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1923247","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1923247"}}